{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:53:22Z","timestamp":1790812402063,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"25","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2024,6,14]]},"DOI":"10.1038\/s41388-024-03040-1","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T18:04:11Z","timestamp":1714068251000},"page":"1885-1899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["GSK3\u03b2 and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-3315","authenticated-orcid":false,"given":"Wulin","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-4811","authenticated-orcid":false,"given":"Wenju","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-9158","authenticated-orcid":false,"given":"Jiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0494-7061","authenticated-orcid":false,"given":"Bairong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"3040_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12032-023-01987-x","volume":"40","author":"AA El-Arabey","year":"2023","unstructured":"El-Arabey AA, Alkhalil SS, Al-Shouli ST, Awadalla ME, Alhamdi HW, Almanaa TN, et al. Revisiting macrophages in ovarian cancer microenvironment: development, function, and interaction. Med Oncol. 2023;40:142.","journal-title":"Med Oncol"},{"key":"3040_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02854-5","volume":"23","author":"S Mei","year":"2023","unstructured":"Mei S, Chen X, Wang K, Chen Y. Tumor microenvironment in ovarian cancer peritoneal metastasis. Cancer Cell Int. 2023;23:11.","journal-title":"Cancer Cell Int"},{"key":"3040_CR3","doi-asserted-by":"publisher","first-page":"8930","DOI":"10.3390\/ijms24108930","volume":"24","author":"G Tossetta","year":"2023","unstructured":"Tossetta G, Inversetti A. Ovarian cancer: advances in pathophysiology and therapies. Int J Mol Sci. 2023;24:8930.","journal-title":"Int J Mol Sci"},{"key":"3040_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41392-022-01300-8","volume":"8","author":"F Shu","year":"2023","unstructured":"Shu F, Xiao H, Li QN, Ren XS, Liu ZG, Hu BW, et al. Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. Signal Transduct Target Ther. 2023;8:32.","journal-title":"Signal Transduct Target Ther"},{"key":"3040_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41417-022-00464-3","volume":"30","author":"H Wang","year":"2023","unstructured":"Wang H, Yang L, Liu M, Luo J. Protein post-translational modifications in the regulation of cancer hallmarks. Cancer Gene Ther. 2023;30:529\u201347.","journal-title":"Cancer Gene Ther"},{"key":"3040_CR6","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1002\/mco2.261","volume":"4","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Xiao X, Qiu Y, Xu Z, Chen C, Chong B, et al. Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications. MedComm. 2023;4:e261.","journal-title":"MedComm"},{"key":"3040_CR7","doi-asserted-by":"publisher","first-page":"166594","DOI":"10.1016\/j.bbadis.2022.166594","volume":"1869","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Xu H, Wei Y, Sun L, Song Y. Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC. Biochim Biophys Acta Mol Basis Dis. 2023;1869:166594.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3040_CR8","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan S, Chen R. Pathological implication of protein post-translational modifications in cancer. Mol Aspects Med. 2022;86:101097.","journal-title":"Mol Aspects Med"},{"key":"3040_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41418-021-00862-4","volume":"29","author":"C Ren","year":"2022","unstructured":"Ren C, Han X, Lu C, Yang T, Qiao P, Sun Y, et al. Ubiquitination of NF-\u03baB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance. Cell Death Differ. 2022;29:381\u201392.","journal-title":"Cell Death Differ"},{"key":"3040_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38605-3","volume":"14","author":"X Xiao","year":"2023","unstructured":"Xiao X, Shi J, He C, Bu X, Sun Y, Gao M, et al. ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nat Commun. 2023;14:2859.","journal-title":"Nat Commun"},{"key":"3040_CR11","doi-asserted-by":"publisher","first-page":"104572","DOI":"10.1016\/j.jbc.2023.104572","volume":"299","author":"Y Peng","year":"2023","unstructured":"Peng Y, Liu J, Inuzuka H, Wei W. Targeted protein posttranslational modifications by chemically induced proximity for cancer therapy. J Biol Chem. 2023;299:104572.","journal-title":"J Biol Chem"},{"key":"3040_CR12","doi-asserted-by":"publisher","first-page":"5946","DOI":"10.18632\/aging.204195","volume":"14","author":"G Li","year":"2022","unstructured":"Li G, Xu Z, Peng J, Yan Y, Liu Y, Zhang X, et al. The RIPK family: expression profile and prognostic value in lung adenocarcinoma. Aging. 2022;14:5946\u201358.","journal-title":"Aging"},{"key":"3040_CR13","doi-asserted-by":"publisher","first-page":"106613","DOI":"10.1016\/j.phrs.2022.106613","volume":"187","author":"FY Huang","year":"2023","unstructured":"Huang FY, Dai SZ, Xu WT, Xiong W, Sun Y, Huang YH, et al. 3\u2019-epi-12\u03b2-hydroxyfroside-mediated autophagy degradation of RIPK1\/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells. Pharmacol Res. 2023;187:106613.","journal-title":"Pharmacol Res"},{"key":"3040_CR14","doi-asserted-by":"publisher","first-page":"7599098","DOI":"10.1155\/2022\/7599098","volume":"2022","author":"C Liao","year":"2022","unstructured":"Liao C, Zhao YX, Han WD, Lai NY. RIPK4 is an immune regulating-associated biomarker for ovarian cancer and possesses generalization value in pan-cancer. J Immunol Res. 2022;2022:7599098.","journal-title":"J Immunol Res"},{"key":"3040_CR15","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.3390\/cancers14215237","volume":"14","author":"GY Zhong","year":"2022","unstructured":"Zhong GY, Tan JN, Huang J, Zhou SN, Yu JH, Zhong L, et al. LncRNA LINC01537 promotes gastric cancer metastasis and tumorigenesis by stabilizing RIPK4 to activate NF-\u03baB signaling. Cancers. 2022;14:5237.","journal-title":"Cancers"},{"key":"3040_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ddr.21871","volume":"83","author":"A Jin","year":"2022","unstructured":"Jin A, Zhang L, Fang G, Chen Y. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta. Drug Dev Res. 2022;83:407\u201315.","journal-title":"Drug Dev Res"},{"key":"3040_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/cancers15030737","volume":"15","author":"Y Yan","year":"2023","unstructured":"Yan Y, Gauthier MA, Malik A, Fotiadou I, Ostrovski M, Dervovic D, et al. The NOTCH-RIPK4-IRF6-ELOVL4 axis suppresses squamous cell carcinoma. Cancers. 2023;15:737.","journal-title":"Cancers"},{"key":"3040_CR18","first-page":"1695","volume":"17","author":"WY Pan","year":"2019","unstructured":"Pan WY, Zeng JH, Wen DY, Wang JY, Wang PP, Chen G, et al. Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation. Oncol Lett. 2019;17:1695\u2013713.","journal-title":"Oncol Lett"},{"key":"3040_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/21655979.2021.1871817","volume":"12","author":"L Cai","year":"2021","unstructured":"Cai L, Ye L, Hu X, He W, Zhuang D, Guo Q, et al. MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4. Bioengineered. 2021;12:440\u20139.","journal-title":"Bioengineered"},{"key":"3040_CR20","doi-asserted-by":"publisher","first-page":"106627","DOI":"10.1016\/j.phrs.2022.106627","volume":"188","author":"QQ Zhou","year":"2023","unstructured":"Zhou QQ, Xiao HT, Yang F, Wang YD, Li P, Zheng ZG. Advancing targeted protein degradation for metabolic diseases therapy. Pharmacol Res. 2023;188:106627.","journal-title":"Pharmacol Res"},{"key":"3040_CR21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/ijms19041080","volume":"19","author":"N Nakamura","year":"2018","unstructured":"Nakamura N. Ubiquitin system. Int J Mol Sci. 2018;19:1080.","journal-title":"Int J Mol Sci"},{"key":"3040_CR22","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/0008-5472.CAN-22-1812","volume":"83","author":"Y Ren","year":"2023","unstructured":"Ren Y, Feng M, Hao X, Liu X, Li J, Li P, et al. USP48 stabilizes gasdermin e to promote pyroptosis in cancer. Cancer Res. 2023;83:1074\u201393.","journal-title":"Cancer Res"},{"key":"3040_CR23","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/s41418-023-01134-z","volume":"30","author":"J Tang","year":"2023","unstructured":"Tang J, Yang Q, Mao C, Xiao D, Liu S, Xiao L, et al. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway. Cell Death Differ. 2023;30:1247\u201359.","journal-title":"Cell Death Differ"},{"key":"3040_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-020-0181-3","volume":"5","author":"L Ouyang","year":"2020","unstructured":"Ouyang L, Yan B, Liu Y, Mao C, Wang M, Liu N, et al. The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor. Signal Transduct Target Ther. 2020;5:78.","journal-title":"Signal Transduct Target Ther"},{"key":"3040_CR25","doi-asserted-by":"publisher","first-page":"106276","DOI":"10.1016\/j.isci.2023.106276","volume":"26","author":"H Barbour","year":"2023","unstructured":"Barbour H, Nkwe NS, Estavoyer B, Messmer C, Gushul-Leclaire M, Villot R, et al. An inventory of crosstalk between ubiquitination and other post-translational modifications in orchestrating cellular processes. iScience. 2023;26:106276.","journal-title":"iScience"},{"key":"3040_CR26","doi-asserted-by":"publisher","first-page":"104570","DOI":"10.1016\/j.jbc.2023.104570","volume":"299","author":"L Hu","year":"2023","unstructured":"Hu L, Liu M, Tang B, Li Q, Pan BS, Xu C, et al. Posttranslational regulation of liver kinase B1 in human cancer. J Biol Chem. 2023;299:104570.","journal-title":"J Biol Chem"},{"key":"3040_CR27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s12079-023-00745-y","volume":"17","author":"P Khilar","year":"2023","unstructured":"Khilar P, Sruthi KK, Parveen SMA, Natani S, Jadav SS, Ummanni R. AMPK targets a proto-oncogene TPD52 (isoform 3) expression and its interaction with LKB1 suppress AMPK-GSK3\u03b2 signaling axis in prostate cancer. J Cell Commun Signal. 2023;17:957\u201374.","journal-title":"J Cell Commun Signal"},{"key":"3040_CR28","first-page":"1154","volume":"21","author":"Z Yi","year":"2020","unstructured":"Yi Z, Pu Y, Gou R, Chen Y, Ren X, Liu W, et al. Silencing of RIPK4 inhibits epithelial\u2011mesenchymal transition by inactivating the Wnt\/\u03b2\u2011catenin signaling pathway in osteosarcoma. Mol Med Rep. 2020;21:1154\u201362.","journal-title":"Mol Med Rep"},{"key":"3040_CR29","first-page":"6622439","volume":"2021","author":"S Liu","year":"2021","unstructured":"Liu S, He L, Sheng C, Su R, Wu X, Sun Y, et al. Overexpression of RIPK4 predicts poor prognosis and promotes metastasis in ovarian cancer. BioMed Res Int. 2021;2021:6622439.","journal-title":"BioMed Res Int"},{"key":"3040_CR30","doi-asserted-by":"publisher","first-page":"10789","DOI":"10.3390\/ijms231810789","volume":"23","author":"Y Ren","year":"2022","unstructured":"Ren Y, Yu B, Zhou L, Wang F, Wang Y. Structural Insights into the phosphorylation-enhanced deubiquitinating activity of UCHL3 and ubiquitin chain cleavage preference analysis. Int J Mol Sci. 2022;23:10789.","journal-title":"Int J Mol Sci"},{"key":"3040_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbrc.2022.11.065","volume":"641","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu JB, Liu J, Liu M, Liu HL, Zhang J. UCHL3 promotes cervical cancer development and metastasis by stabilizing NRF2 via deubiquitination. Biochem Biophys Res Commun. 2023;641:132\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"3040_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41388-019-0987-z","volume":"39","author":"MH Zhang","year":"2020","unstructured":"Zhang MH, Zhang HH, Du XH, Gao J, Li C, Shi HR, et al. UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-\u03baB pathway. Oncogene. 2020;39:322\u201333.","journal-title":"Oncogene"},{"key":"3040_CR33","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1101\/gad.289439.116","volume":"30","author":"K Luo","year":"2016","unstructured":"Luo K, Li L, Li Y, Wu C, Yin Y, Chen Y, et al. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination. Genes Dev. 2016;30:2581\u201395.","journal-title":"Genes Dev"},{"key":"3040_CR34","doi-asserted-by":"publisher","first-page":"585259","DOI":"10.3389\/fgene.2020.585259","volume":"11","author":"L Liu","year":"2020","unstructured":"Liu L, Cai L, Liu C, Yu S, Li B, Pan L, et al. Construction and validation of a novel glycometabolism-related gene signature predicting survival in patients with ovarian cancer. Front Genetics. 2020;11:585259.","journal-title":"Front Genetics"},{"key":"3040_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3917-x","volume":"18","author":"Y Guo","year":"2018","unstructured":"Guo Y, Zeng H, Chang X, Wang C, Cui H. Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models. BMC Cancer. 2018;18:81.","journal-title":"BMC Cancer"},{"key":"3040_CR36","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s12094-021-02565-1","volume":"23","author":"Y Fan","year":"2021","unstructured":"Fan Y, Hu D, Li D, Ma C, Tang Y, Tao Q, et al. UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression. Clin Transl Oncol. 2021;23:1637\u201345.","journal-title":"Clin Transl Oncol"},{"key":"3040_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34747-y","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Luo M, Wang F, Tong Y, Li L, Shu Y, et al. AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis. Nat Commun. 2022;13:7215.","journal-title":"Nat Commun"},{"key":"3040_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02146-3","volume":"8","author":"H Lu","year":"2017","unstructured":"Lu H, Shamanna RA, de Freitas JK, Okur M, Khadka P, Kulikowicz T, et al. Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair. Nat Commun. 2017;8:2039.","journal-title":"Nat Commun"},{"key":"3040_CR39","doi-asserted-by":"publisher","first-page":"103481","DOI":"10.1016\/j.drudis.2022.103481","volume":"28","author":"MA Khan","year":"2023","unstructured":"Khan MA, Tania M. Cordycepin and kinase inhibition in cancer. Drug Discov Today. 2023;28:103481.","journal-title":"Drug Discov Today"},{"key":"3040_CR40","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41419-022-05500-6","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Gao F, Li X, Gan Y, Han S, Yu X, et al. Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance. Cell Death Dis. 2022;13:1053.","journal-title":"Cell Death Dis"},{"key":"3040_CR41","doi-asserted-by":"publisher","first-page":"110526","DOI":"10.1016\/j.cellsig.2022.110526","volume":"101","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen S, Peng C. GSK-3\u03b2 phosphorylation of DHX33 leads to its ubiquitination mediated protein degradation. Cell Signal. 2023;101:110526.","journal-title":"Cell Signal"},{"key":"3040_CR42","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.15252\/embj.201695679","volume":"36","author":"P Lee","year":"2017","unstructured":"Lee P, Jiang S, Li Y, Yue J, Gou X, Chen SY, et al. Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis. EMBO J. 2017;36:1963\u201380.","journal-title":"EMBO J"},{"key":"3040_CR43","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1126\/science.1232253","volume":"339","author":"X Huang","year":"2013","unstructured":"Huang X, McGann JC, Liu BY, Hannoush RN, Lill JR, Pham V, et al. Phosphorylation of Dishevelled by protein kinase RIPK4 regulates Wnt signaling. Science. 2013;339:1441\u20135.","journal-title":"Science"},{"key":"3040_CR44","doi-asserted-by":"publisher","first-page":"32226","DOI":"10.1021\/acsami.3c04949","volume":"15","author":"T Pu","year":"2023","unstructured":"Pu T, Liu Y, Pei Y, Peng J, Wang Z, Du M, et al. NIR-II fluorescence imaging for the detection and resection of cancerous foci and lymph nodes in early-stage orthotopic and advanced-stage metastatic ovarian cancer models. ACS Appl Mater Interfaces. 2023;15:32226\u201339.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3040_CR45","doi-asserted-by":"publisher","first-page":"476","DOI":"10.14348\/molcells.2023.0011","volume":"46","author":"JH Lee","year":"2023","unstructured":"Lee JH, Park SA, Park IG, Yoon BK, Lee JS, Lee JM. Stem cell properties of gastric cancer stem-like cells under stress conditions are regulated via the c-Fos\/UCH-L3\/\u03b2-catenin axis. Mol Cells. 2023;46:476\u201385.","journal-title":"Mol Cells"},{"key":"3040_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/19768354.2021.1987320","volume":"25","author":"JE Lee","year":"2021","unstructured":"Lee JE, Lim YH, Kim JH. UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3K\/Akt signaling pathway in prostate cancer cells. Anim Cells Syst. 2021;25:312\u201322.","journal-title":"Anim Cells Syst"},{"key":"3040_CR47","doi-asserted-by":"publisher","first-page":"eaaw6499","DOI":"10.1126\/sciadv.aaw6499","volume":"5","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang Y, Zeng Q, Zeng H, Liu X, Wu P, et al. Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes. Sci Adv. 2019;5:eaaw6499.","journal-title":"Sci Adv"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03040-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T08:05:51Z","timestamp":1718352351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03040-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":47,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,6,14]]}},"alternative-id":["3040"],"URL":"https:\/\/doi.org\/10.1038\/s41388-024-03040-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study involving human participants and animals was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of USTC. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}